Investigating Whether Digital Acceptance Commitment Therapy Can Improve Mental Health for Hong Kong Cancer Patients Suffering From Depressive and Anxiety Symptoms.

NCT ID: NCT05583851

Last Updated: 2022-10-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-01

Study Completion Date

2023-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to validate the use of digital Acceptance and Commitment Therapy (Digi-ACT) in Hong Kong curative cancer patients with depressive and anxiety symptoms. The main questions it aims to answer are:

* Can Digi-ACT reduce depressive or anxiety symptoms?
* Can Digi-ACT improved health-related quality of life?
* Is Digi-ACT an acceptable and feasible intervention for users?
* What are the factors that influence the success of Digi-ACT?
* Can the video journals used in Digi-ACT predict depressive symptoms?

Intervention group participants will install the Digi-ACT mobile application and undergo a 3-4 week long intervention. They will have to fill out questionnaires at baseline, immediately after the intervention, and at three month follow up to measure depression and anxiety symptoms, health-related quality of life, acceptability of the intervention, and other process outcomes related to the intervention itself.

Researchers will compare the outcomes with a group of participants that undergo a 3-4 week long period where they navigate a similar mobile platform that gives bi-daily psychoeducational videos that also fill out the same clinical questionnaires at baseline, post-intervention, and at three month follow up.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with cancer experience increased rates and severity of depression and anxiety symptoms. This could be due to difficulty dealing with the diagnostic process, treatment side effects, limited social opportunities, physical symptoms, and other cancer-related complications. Acceptance and Commitment Therapy (ACT) has proven to be effective in treating these symptoms for cancer patients. Compared to other evidence based therapies, such as second wave cognitive behavioral therapy (CBT), ACT has shown to have larger effect sizes and success in treating this population. One possible explanation could be due to the theoretical and practical approaches of ACT over traditional CBT. Traditional CBT aims to identify illogical thought patterns that are biased or distorted and try to change them, while ACT makes no attempt at changing these thought patterns and simply teaches the participant to accept and experience these thoughts, emotions, and sensations. For cancer patients, feelings of depression when faced with their own mortality, are unavoidable and could be invalidating if told they are "illogical" or "distorted". Therefore, ACT may have the advantage here in recognizing the severity of the cancer journey and providing an alternative way that does not try to change their experiences.

Furthermore, Hong Kong has a persisting mental health treatment gap due to insufficient mental health practitioners. Oftentimes, only moderate to severe cases of common mental disorders are addressed, thereby leaving milder cases untreated. A possible solution to such under-treatment is digital Health, which requires no additional practitioners and has shown promising results in past studies.

Therefore, we aim to test the efficacy, acceptability, and feasibility of a digitized version (mobile application) of ACT for cancer patients in Hong Kong.

We aim to answer several key questions with the current randomized controlled trial (RCT):

* Can Digi-ACT reduce depressive and anxiety symptoms from baseline to post-treatment and will this reduction be sustained at three month follow up?
* Can Digi-ACT improve health related quality of life from baseline to post-treatment and will this reduction be sustained at three month follow up?
* Is Digi-ACT perceived as an acceptable intervention prior to use? How about after use?
* Can different ACT process measures moderate the relationship between treatment and clinical outcomes?

Research assistants from Hollo will collaborate with Queen Mary Hospital's Oncological unit and Hong Kong Private Clinic: "Oncare" to recruit 50 Cancer patients for the pilot trial within the inclusion criteria. Participants will be screened at baseline for measures of depression and anxiety. Those that score mild or moderate will be invited to participate in the study. Upon providing informed consent, participants will be instructed to download the Hollo Digi-ACT mobile application.

Participants will be randomly allocated to either intervention or active control. Over 4 weeks, participants in the intervention group will be administered the digitized ACT on their mobile device while those in the active control will receive various educational mental health videos over the 4 weeks. After the completion of the intervention, participants will fill out the same clinical indexes and then a final time 3 months later.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression, Anxiety Quality of Life Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Digi-ACT Intervention group

22 day long interactive mobile app intervention with daily activities. The intervention will include 5 total modules: psychoeducation on depression/anxiety and the cancer journey; acceptance; cognitive fusion; mindfulness; and committed valued living. There will be different games and reward components for the Through out the course of the intervention, participants will also do video journals to reflect on the different modules and activities they do.

Group Type EXPERIMENTAL

Acceptance and Commitment Therapy

Intervention Type DEVICE

Smartphone app guided and manualized version of acceptance and commitment therapy.

Psychoeducational Video Control group

22 day long mobile app where participants will be given a 15 minute long psychoeducational clip from a publicly available online seminar (from the Hong Kong College of Psychiatrists) on a bi-daily basis. Through out the course of the intervention, participants will also do video journals to reflect on the content of the different video clips.

Group Type ACTIVE_COMPARATOR

Psychoeducation Active Control

Intervention Type OTHER

Set of 11 public seminar videos regarding depression and anxiety. Each are 15 minutes long.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Acceptance and Commitment Therapy

Smartphone app guided and manualized version of acceptance and commitment therapy.

Intervention Type DEVICE

Psychoeducation Active Control

Set of 11 public seminar videos regarding depression and anxiety. Each are 15 minutes long.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Digi-ACT Digital Acceptance and Commitment Therapy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18 and above
* PHQ-9 score of 5 to 14
* BAI score of 8 to 25
* Fluent in Cantonese or Mandarin
* Diagnosed with stage 0 to 3 cancer
* Received surgery as primary treatment at least four months ago

Exclusion Criteria

* Diagnosed with metastatic cancer (stage 4)
* Language/intellectual difficulties
* Prior diagnoses of other psychiatric conditions other than unipolar depression or anxiety
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

OnCare Hong Kong

UNKNOWN

Sponsor Role collaborator

The University of Hong Kong

OTHER

Sponsor Role collaborator

Hollo

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Duncan Lim

Cognitive Scientist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wendy Wing-lok Chan, MBBS

Role: PRINCIPAL_INVESTIGATOR

LKS Faculty of Medicine, HKU

Kevin Ka Ming Wong, MBBS

Role: PRINCIPAL_INVESTIGATOR

OnCare Hong Kong

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tun Hoi Duncan Lim, MSc

Role: CONTACT

97872500 ext. 852

Cameron Van Breda, BS

Role: CONTACT

64035861 ext. 852

References

Explore related publications, articles, or registry entries linked to this study.

Bai Z, Luo S, Zhang L, Wu S, Chi I. Acceptance and Commitment Therapy (ACT) to reduce depression: A systematic review and meta-analysis. J Affect Disord. 2020 Jan 1;260:728-737. doi: 10.1016/j.jad.2019.09.040. Epub 2019 Sep 10.

Reference Type BACKGROUND
PMID: 31563072 (View on PubMed)

Barnes-Holmes Y, Hayes SC, Barnes-Holmes D, Roche B. Relational frame theory: a post-Skinnerian account of human language and cognition. Adv Child Dev Behav. 2001;28:101-38. doi: 10.1016/s0065-2407(02)80063-5. No abstract available.

Reference Type BACKGROUND
PMID: 11605362 (View on PubMed)

Che, Lu, Chen, Chang. Validation of the Chinese Version of the Beck Anxiety Inventory. 台灣醫學. 1006; 447-454.

Reference Type BACKGROUND

Cheung G, Douwes G, Sundram F. Late-Life Suicide in Terminal Cancer: A Rational Act or Underdiagnosed Depression? J Pain Symptom Manage. 2017 Dec;54(6):835-842. doi: 10.1016/j.jpainsymman.2017.05.004. Epub 2017 Aug 12.

Reference Type BACKGROUND
PMID: 28807701 (View on PubMed)

Cillessen L, Johannsen M, Speckens AEM, Zachariae R. Mindfulness-based interventions for psychological and physical health outcomes in cancer patients and survivors: A systematic review and meta-analysis of randomized controlled trials. Psychooncology. 2019 Dec;28(12):2257-2269. doi: 10.1002/pon.5214. Epub 2019 Sep 11.

Reference Type BACKGROUND
PMID: 31464026 (View on PubMed)

Cotter DD. Psychometric evaluation of the Valued Living Questionnaire: Comparing distressed and normative samples. Western Michigan University. 2011.

Reference Type BACKGROUND

Deng Y, Li S, Tang, Zhu L, Ryan R, Brown K. Psychometric properties of the Chinese translation of the mindful attention awareness scale (MAAS). Mindfulness. 2012; 3(1), 10-14.

Reference Type BACKGROUND

Fitzpatrick KK, Darcy A, Vierhile M. Delivering Cognitive Behavior Therapy to Young Adults With Symptoms of Depression and Anxiety Using a Fully Automated Conversational Agent (Woebot): A Randomized Controlled Trial. JMIR Ment Health. 2017 Jun 6;4(2):e19. doi: 10.2196/mental.7785.

Reference Type BACKGROUND
PMID: 28588005 (View on PubMed)

Gillanders DT, Bolderston H, Bond FW, Dempster M, Flaxman PE, Campbell L, Kerr S, Tansey L, Noel P, Ferenbach C, Masley S, Roach L, Lloyd J, May L, Clarke S, Remington B. The development and initial validation of the cognitive fusion questionnaire. Behav Ther. 2014 Jan;45(1):83-101. doi: 10.1016/j.beth.2013.09.001. Epub 2013 Sep 18.

Reference Type BACKGROUND
PMID: 24411117 (View on PubMed)

Graham CD, Gouick J, Krahe C, Gillanders D. A systematic review of the use of Acceptance and Commitment Therapy (ACT) in chronic disease and long-term conditions. Clin Psychol Rev. 2016 Jun;46:46-58. doi: 10.1016/j.cpr.2016.04.009. Epub 2016 Apr 20.

Reference Type BACKGROUND
PMID: 27176925 (View on PubMed)

Hayes SC. Buddhism and acceptance and commitment therapy. Cognitive and Behavioral Practice. 2002; 9(1), 58-66.

Reference Type BACKGROUND

Hayes SC. Get out of your mind and into your life: The new acceptance and commitment therapy. New Harbinger Publications. 2005.

Reference Type BACKGROUND

Hayes SC, Strosahl KD, Wilson KG. Acceptance and commitment therapy. Washington, DC: American Psychological Association. 2009.

Reference Type BACKGROUND

Hinz A, Krauss O, Hauss JP, Hockel M, Kortmann RD, Stolzenburg JU, Schwarz R. Anxiety and depression in cancer patients compared with the general population. Eur J Cancer Care (Engl). 2010 Jul;19(4):522-9. doi: 10.1111/j.1365-2354.2009.01088.x. Epub 2009 Dec 17.

Reference Type BACKGROUND
PMID: 20030697 (View on PubMed)

Kim J, Shin W. How to do random allocation (randomization). Clin Orthop Surg. 2014 Mar;6(1):103-9. doi: 10.4055/cios.2014.6.1.103. Epub 2014 Feb 14.

Reference Type BACKGROUND
PMID: 24605197 (View on PubMed)

Kioskli K, Scott W, Winkley K, Godfrey E, McCracken LM. Online Acceptance and Commitment Therapy for People with Painful Diabetic Neuropathy in the United Kingdom: A Single-Arm Feasibility Trial. Pain Med. 2020 Nov 1;21(11):2777-2788. doi: 10.1093/pm/pnaa110.

Reference Type BACKGROUND
PMID: 32358608 (View on PubMed)

Li H, Wong CL, Jin X, Chen J, Chong YY, Bai Y. Effects of Acceptance and Commitment Therapy on health-related outcomes for patients with advanced cancer: A systematic review. Int J Nurs Stud. 2021 Mar;115:103876. doi: 10.1016/j.ijnurstu.2021.103876. Epub 2021 Jan 12.

Reference Type BACKGROUND
PMID: 33517079 (View on PubMed)

Lin J, Paganini S, Sander L, Luking M, Ebert DD, Buhrman M, Andersson G, Baumeister H. An Internet-Based Intervention for Chronic Pain. Dtsch Arztebl Int. 2017 Oct 13;114(41):681-688. doi: 10.3238/arztebl.2017.0681.

Reference Type BACKGROUND
PMID: 29082858 (View on PubMed)

Luoma JB, Hayes SC, Walser RD. Learning ACT: An acceptance & commitment therapy skills-training manual for therapists. New Harbinger Publications. 2007.

Reference Type BACKGROUND

Masuda A, Hayes SC, Sackett CF, Twohig MP. Cognitive defusion and self-relevant negative thoughts: examining the impact of a ninety year old technique. Behav Res Ther. 2004 Apr;42(4):477-85. doi: 10.1016/j.brat.2003.10.008.

Reference Type BACKGROUND
PMID: 14998740 (View on PubMed)

Men VY, Emery CR, Yip PSF. Characteristics of cancer patients who died by suicide: A quantitative study of 15-year coronial records. Psychooncology. 2021 Jul;30(7):1051-1058. doi: 10.1002/pon.5634. Epub 2021 Mar 2.

Reference Type BACKGROUND
PMID: 33655563 (View on PubMed)

Menin J, de Blasio B. New York city mobile services study. Research Brief, Department of Consumer Affairs, New York City. 2015.

Reference Type BACKGROUND

Ost LG. The efficacy of Acceptance and Commitment Therapy: an updated systematic review and meta-analysis. Behav Res Ther. 2014 Oct;61:105-21. doi: 10.1016/j.brat.2014.07.018. Epub 2014 Aug 19.

Reference Type BACKGROUND
PMID: 25193001 (View on PubMed)

Pitman A, Suleman S, Hyde N, Hodgkiss A. Depression and anxiety in patients with cancer. BMJ. 2018 Apr 25;361:k1415. doi: 10.1136/bmj.k1415. No abstract available.

Reference Type BACKGROUND
PMID: 29695476 (View on PubMed)

Rodriguez MA, Jia K, Qian MY. White Bear Suppression Inventory: Structure, reliability and validity of the Chinese version. Chinese Journal of Clinical Psychology. 2012.

Reference Type BACKGROUND

Razzouk R, Shute V. What is design thinking and why is it important?. Review of educational research. 2012; 82(3): 330-348.

Reference Type BACKGROUND

Simister HD, Tkachuk GA, Shay BL, Vincent N, Pear JJ, Skrabek RQ. Randomized Controlled Trial of Online Acceptance and Commitment Therapy for Fibromyalgia. J Pain. 2018 Jul;19(7):741-753. doi: 10.1016/j.jpain.2018.02.004. Epub 2018 Mar 2.

Reference Type BACKGROUND
PMID: 29481976 (View on PubMed)

Tatrow K, Montgomery GH. Cognitive behavioral therapy techniques for distress and pain in breast cancer patients: a meta-analysis. J Behav Med. 2006 Feb;29(1):17-27. doi: 10.1007/s10865-005-9036-1. Epub 2006 Jan 7.

Reference Type BACKGROUND
PMID: 16400532 (View on PubMed)

Trompetter HR, Bohlmeijer ET, Veehof MM, Schreurs KM. Internet-based guided self-help intervention for chronic pain based on Acceptance and Commitment Therapy: a randomized controlled trial. J Behav Med. 2015 Feb;38(1):66-80. doi: 10.1007/s10865-014-9579-0. Epub 2014 Jun 13.

Reference Type BACKGROUND
PMID: 24923259 (View on PubMed)

van de Graaf DL, Trompetter HR, Smeets T, Mols F. Online Acceptance and Commitment Therapy (ACT) interventions for chronic pain: A systematic literature review. Internet Interv. 2021 Oct 1;26:100465. doi: 10.1016/j.invent.2021.100465. eCollection 2021 Dec.

Reference Type BACKGROUND
PMID: 34660209 (View on PubMed)

Wang W, Bian Q, Zhao Y, Li X, Wang W, Du J, Zhang G, Zhou Q, Zhao M. Reliability and validity of the Chinese version of the Patient Health Questionnaire (PHQ-9) in the general population. Gen Hosp Psychiatry. 2014 Sep-Oct;36(5):539-44. doi: 10.1016/j.genhosppsych.2014.05.021. Epub 2014 Jun 6.

Reference Type BACKGROUND
PMID: 25023953 (View on PubMed)

Wegner DM, Zanakos S. Chronic thought suppression. J Pers. 1994 Dec;62(4):616-40. doi: 10.1111/j.1467-6494.1994.tb00311.x.

Reference Type BACKGROUND
PMID: 7861307 (View on PubMed)

Wei-Chen Z, Yang J, Li X, Hui-Na G, Zhuo-Hong Z. Reliability and validity of the Chinese version of the Cognitive Fusion Questionnaire. Chinese Mental Health Journal. 2014;28(1): 40-44.

Reference Type BACKGROUND

Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res. 2016 Jun;25(3):1057-73. doi: 10.1177/0962280215588241. Epub 2015 Jun 19.

Reference Type BACKGROUND
PMID: 26092476 (View on PubMed)

Yu CL, Fielding R, Chan CL, Tse VK, Choi PH, Lau WH, Choy DT, O SK, Lee AW, Sham JS. Measuring quality of life of Chinese cancer patients: A validation of the Chinese version of the Functional Assessment of Cancer Therapy-General (FACT-G) scale. Cancer. 2000 Apr 1;88(7):1715-27.

Reference Type BACKGROUND
PMID: 10738232 (View on PubMed)

Yu X, Tam WW, Wong PT, Lam TH, Stewart SM. The Patient Health Questionnaire-9 for measuring depressive symptoms among the general population in Hong Kong. Compr Psychiatry. 2012 Jan;53(1):95-102. doi: 10.1016/j.comppsych.2010.11.002. Epub 2010 Dec 28.

Reference Type BACKGROUND
PMID: 21193179 (View on PubMed)

Zhao C, Lai L, Zhang L, Cai Z, Ren Z, Shi C, Luo W, Yan Y. The effects of acceptance and commitment therapy on the psychological and physical outcomes among cancer patients: A meta-analysis with trial sequential analysis. J Psychosom Res. 2021 Jan;140:110304. doi: 10.1016/j.jpsychores.2020.110304. Epub 2020 Nov 20.

Reference Type BACKGROUND
PMID: 33248396 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Project Axolotl

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ACT-based EMI in College Students
NCT06843395 NOT_YET_RECRUITING NA